SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is soaring on reports of a strategic partnership with Novo Nordisk to distribute obesity drugs, effectively ending their previous legal dispute. The community is actively anticipating a massive short squeeze, with widespread calls to hold shares and discussions of potential GME-like rallies due to high short interest.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as the G7 and IEA announced a historic, coordinated release of strategic oil reserves to combat supply shocks from the escalating Iran crisis, while the community debates if this intervention will curb surging prices or if ongoing production cuts and Strait of Hormuz threats suggest further upside.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending due to rapidly escalating geopolitical tensions in the Middle East, with reports of strikes on oil infrastructure and major disruptions to the Strait of Hormuz causing crude oil prices to surge dramatically. The community is actively discussing a potential massive short squeeze, anticipating significant upside given the severe global supply shock and the stock's historical responsiveness to oil price rallies.

ProShares Trust - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is experiencing significant volatility driven by escalating Middle East tensions and reports of Israeli airstrikes on Iranian oil infrastructure, which prompted a historic 400 million barrel strategic reserve release by the G7 and IEA. The market is sharply divided on whether this intervention will hold, or if prices will rebound amid persistent supply concerns and geopolitical uncertainty.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending amidst a sharp stock decline following its HLP004 Phase 2 GAD trial results, as the community grapples with interpreting the 'signal detection' study and management's communication, while many maintain focus on the company's primary HLP003 Phase 3 MDD asset.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is seeing increased conversation driven by its Fast Track Designation for lifileucel in non-small cell lung cancer and strong commercialization momentum for its approved melanoma therapy. This strong pipeline and market execution are fueling optimism about a potential major re-rating and creating significant short-squeeze potential as the company expands its innovative TIL therapy platform.

Permian Resources Holdings, Inc. engages in the exploration and production of oil and natural gas. It also focuses on driving sustainable returns through the responsible acquisition, optimization, and development of crude oil. The company was founded on October 6, 2014 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is actively discussed as extreme crude oil price volatility, fueled by geopolitical tensions, coincides with the company's recent strong earnings and raised guidance, prompting community frustration that its stock price has not yet fully reflected the surging commodity.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending after reporting robust quarterly earnings driven by strong e-commerce and advertising growth, coupled with a significant share buyback and dividend increase. The community is actively discussing its valuation and future guidance, with many highlighting its transformation into a tech-driven retail powerhouse, while others express caution regarding its current pricing.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending as the imminent departure of a key FDA official ignites community speculation for a more lenient regulatory path for its Huntington's disease gene therapy, AMT-130, creating a fierce debate between optimists anticipating approval and skeptics citing unproven efficacy and past roadblocks.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as escalating Middle East tensions, particularly the effective disruption of the Strait of Hormuz and attacks on critical oil infrastructure, are driving a significant surge in global crude prices. The community is actively debating whether this signals a sustained "physical squeeze" on supply, prompting a broader market repricing of inflation risk and a rotation into energy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ACRE Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.07 up 65.00% YoY
• Reported revenue of $13.22M down -24.52% YoY
• Ares Commercial Real Estate Corp&#39;s board declared a regular cash dividend of $0.15 per common share for the first quarter of 2026, payable April 15, 2026. ACRE also expects to pursue increased investment activity.

Stocktwits

Ares Commercial Real Estate Corp

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$0.07 up 65.00% YoY
• Reported revenue of $13.22M down -24.52% YoY
• Ares Commercial Real Estate Corp's board declared a regular cash dividend of $0.15 per common share for the first quarter of 2026, payable April 15, 2026. ACRE also expects to pursue increased investment activity.